Recently, Huize and Sino British Life Insurance jointly launched a customized dividend insurance called "Fumanjia Lifetime Insurance (dividend type)" (hereinafter referred to as Fumanjia). Fumanjia adopts a "minimum guaranteed 2.5% compound interest+expected dividend X" design, which provides the opportunity to obtain potential surplus returns while ensuring the determined cash value of policy benefits.
It is reported that Fumanjia has four options for dividend collection: cash collection, cumulative interest generation, premium offset, and net increase payment. The official website query interest rate for cumulative interest generation is 3.3%. In April 2024, the dividend interest rate was 2.75%. From a deterministic perspective, Fumanjia guarantees that the fastest return on investment is 5 years, exceeding the closing period, and the minimum guaranteed cash value of the contract is 2.5% compound interest appreciation; From the income demonstration, Fumanjia has paid a premium of 7 years over the principal in 5 years, ensuring a long-term IRR (internal rate of return) of 2.3%, a long-term dividend IRR of 3.7%, a dividend IRR of 2.8% in the 10th year, a dividend IRR of over 3.0% in the 12th year, and a dividend IRR of 3.5% in the 24th year.
Data shows that the average comprehensive investment return rate of China UK Life Insurance in the past three years is 5.93%, ranking among the top 4 in the industry with a comprehensive investment return rate of 6.42% in 2023, and ranking among the top 2 in the industry with a latest comprehensive solvency of 273.5% and a core solvency of 167.1% in the fourth quarter of 2023. It has received regulatory Class A evaluations for 29 consecutive quarters.
Zhongying Life Insurance stated that in the context of declining interest rates, regulations will provide guidance on the guaranteed interest rates and demonstration returns for future dividend insurance product development. Currently, Fumanjia not only guarantees high returns, but also demonstrates competitive dividend returns. (Reporter/Su Xianggao Intern Journalist/Yang Xiaohan)